Skip to main content
. Author manuscript; available in PMC: 2017 Apr 7.
Published in final edited form as: Arch Osteoporos. 2015 Oct 19;10:36. doi: 10.1007/s11657-015-0241-4

Table 4. Risk of osteoporotic fracture among Danish subjects with a hospital diagnosis of gout, taking allopurinol, using 1:1 matching.

Hip fracture Major fracture
Men Women All Men Women All
Model 1 1.36 (1.12, 1.66) 1.14 (0.94, 1.39) 1.25 (1.08, 1.44) 1.41 (1.25, 1.58) 1.13 (0.99, 1.29) 1.28 (1.17, 1.39)
Model 2 1.36 (1.1, 1.67) 1.04 (0.85, 1.29) 1.17 (1.01, 1.36) 1.38 (1.22, 1.56) 1.07 (0.93, 1.23) 1.23 (1.13, 1.35)
Model 3 1.44 (1.16, 1.79) 1.04 (0.84, 1.30) 1.21 (1.04, 1.41) 1.43 (1.26, 1.62) 1.08 (0.93, 1.25) 1.26 (1.15, 1.39)

Figures given are HRs, with 95% CIs

Model 1: allopurinol use

Model 2: allopurinol use, prior fracture, known comorbidity

Model3: allopurinol use, prior fracture, known comorbidity, drug history